4.5 Review

Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer

Journal

MOLECULAR MEDICINE REPORTS
Volume 23, Issue 2, Pages -

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2020.11744

Keywords

colorectal cancer; Wnt/beta-catenin signaling; drug resistance; tumor stem cells; non-coding RNAs; tumor microenvironment

Funding

  1. Natural Science Foundation of Jiangxi Province [20202BABL206089]
  2. Natural Science Foundation of Department of Education of Jiangxi Province [GJJ190072]

Ask authors/readers for more resources

The unsatisfactory effect of chemotherapy in colorectal cancer is mainly due to the presence of highly metastatic tumor stem cells, regulation of non-coding RNAs, and the tumor microenvironment. The Wnt/beta-catenin signaling pathway plays a crucial role in mediating chemoresistance in CRC by impacting these factors.
Colorectal cancer (CRC) is the third most common malignant tumor in humans. Chemotherapy is used for the treatment of CRC. However, the effect of chemotherapy remains unsatisfactory due to drug resistance. Growing evidence has shown that the presence of highly metastatic tumor stem cells, regulation of non-coding RNAs and the tumor microenvironment contributes to drug resistance mechanisms in CRC. Wnt/beta-catenin signaling mediates the chemoresistance of CRC in these three aspects. Therefore, the present study analyzed the abundant evidence of the contribution of Wnt/beta-catenin signaling to the development of drug resistance in CRC and discussed its possible role in improving the chemosensitivity of CRC, which may provide guidelines for its clinical treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available